Literature DB >> 24807396

A Comparison of Fentanyl and Flurbiprofen Axetil on Serum VEGF-C, TNF-α, and IL-1ß Concentrations in Women Undergoing Surgery for Breast Cancer.

Yiyun Wen1, Mingde Wang1, Jinfeng Yang1, Yichun Wang2, Huiping Sun1, Jianghong Zhao1, Weizhen Liu1, Zhengyu Zhou3, Hongwu Deng3, Catalina Castillo-Pedraza4, Yi Zhang3, Keith A Candiotti4.   

Abstract

BACKGROUND: Vascular endothelial growth factor-C (VEGF-C), tumor necrosis factor-α (TNF-α), and interleukin-1ß(IL-1ß) have been shown to be associated with the recurrence and metastasis of breast cancer after surgery. This study tested the hypothesis that patients undergoing surgery for breast cancer, who received postoperative analgesia with flurbiprofen axetil combined with small doses of fentanyl (FA), exhibited reduced levels of VEGF-C, TNF-α, and IL-1ß compared with those patients receiving fentanyl alone (F).
METHOD: Forty-women with primary breast cancer undergoing a modified radical mastectomy were randomized to receive postoperative analgesia with flurbiprofen axetil combined with fentanyl or fentanyl alone. Venous blood was sampled before anesthesia, at the end of surgery, and at 48 hours after surgery, and the serum was analyzed. The primary endpoint was changes in the VEGF-C concentrations in serum.
RESULTS: Group FA patients reported similar analgesic effects as group F patients at 2, 24, and 48 hours. At 48 hours, mean postoperative concentrations of VEGF-C in group F patients were higher than in group FA patients, 730.9 versus. 354.1 pg/mL (P = 0.003), respectively. The mean postoperative concentrations of TNF-α in group F patients were also higher compared with group FA patients 27.1 vs. 15.8 pg/mL (P = 0.005). Finally, the mean postoperative concentrations of IL-1ß in group F were also significantly higher than in group FA 497.5 vs. 197.7 pg/mL (P = 0.001).
CONCLUSION: In patients undergoing a mastectomy, postoperative analgesia with flurbiprofen axetil, combined with fentanyl, were associated with decreases in serum concentrations of VEGF-C, TNF-α, and IL-1ß compared with patients receiving doses of only fentanyl.
© 2014 World Institute of Pain.

Entities:  

Keywords:  analgesia; immunologic factors; postoperative pain

Mesh:

Substances:

Year:  2014        PMID: 24807396     DOI: 10.1111/papr.12206

Source DB:  PubMed          Journal:  Pain Pract        ISSN: 1530-7085            Impact factor:   3.183


  11 in total

Review 1.  Perioperative systemic nonsteroidal anti-inflammatory drugs (NSAIDs) in women undergoing breast surgery.

Authors:  Kevin M Klifto; Ala Elhelali; Rachael M Payne; Carisa M Cooney; Michele A Manahan; Gedge D Rosson
Journal:  Cochrane Database Syst Rev       Date:  2021-11-09

2.  Reducing postsurgical exudate in breast cancer patients by using San Huang decoction to ameliorate inflammatory status: a prospective clinical trial.

Authors:  Z Y Zhu; J X Xue; L X Yu; W H Bian; Y F Zhang; K C Sohn; I H Shin; C Yao
Journal:  Curr Oncol       Date:  2018-12-01       Impact factor: 3.677

3.  Effects of preemptive analgesia with flurbiprofen ester on lymphocytes and natural killer cells in patients undergoing esophagectomy: A randomized controlled pilot study.

Authors:  Yi Zhou; Jinxi Huang; Yu Bai; Changsheng Li; Xihua Lu
Journal:  Thorac Cancer       Date:  2017-09-11       Impact factor: 3.500

4.  Flurbiprofen Axetil Enhances Analgesic Effects of Sufentanil and Attenuates Postoperative Emergence Agitation and Systemic Proinflammation in Patients Undergoing Tangential Excision Surgery.

Authors:  Wujun Geng; Wandong Hong; Junlu Wang; Qinxue Dai; Yunchang Mo; Kejian Shi; Jiehao Sun; Jinling Qin; Mei Li; Hongli Tang
Journal:  Mediators Inflamm       Date:  2015-07-27       Impact factor: 4.711

5.  Effect of flurbiprofen axetil on postoperative delirium for elderly patients.

Authors:  Xifan Wang; Yu Wang; Yanan Hu; Liping Wang; Wenshuai Zhao; Lanying Wei; Hong Chen; Fei Han
Journal:  Brain Behav       Date:  2019-04-21       Impact factor: 2.708

6.  Multicentre randomised phase II study of the perioperative administration of flurbiprofen axetil in patients with non-small cell lung cancer: study protocol of the FLAX Study.

Authors:  Kentaro Sakamaki; Katsuya Watanabe; Tetsukan Woo; Munetaka Masuda
Journal:  BMJ Open       Date:  2020-11-30       Impact factor: 2.692

7.  Perioperative NSAIDs and Long-Term Outcomes After cancer Surgery: a Systematic Review and Meta-analysis.

Authors:  Shebin Shaji; Charlotte Smith; Patrice Forget
Journal:  Curr Oncol Rep       Date:  2021-11-08       Impact factor: 5.075

8.  Effects of flurbiprofen on serum level of interleukin-6, prostacyclin and corticosteroid A2 in patients with bone metastases of cancer.

Authors:  Yanwei Yin; Yusheng Yi; Junmin Yu; Xiuming Sun; Chuansheng Liu; Fenghe Xu
Journal:  Oncol Lett       Date:  2017-11-23       Impact factor: 2.967

Review 9.  Which idea is better with regard to immune response? Opioid anesthesia or opioid free anesthesia.

Authors:  Barbara Lisowska; Jakub Jakubiak; Katarzyna Siewruk; Maria Sady; Dariusz Kosson
Journal:  J Inflamm Res       Date:  2020-11-05

Review 10.  Key Factor Regulating Inflammatory Microenvironment, Metastasis, and Resistance in Breast Cancer: Interleukin-1 Signaling.

Authors:  Fengjie Liu; Lihong Li; Meng Lan; Tengteng Zou; Zhaodi Kong; Tiange Cai; Xiao Yu Wu; Yu Cai
Journal:  Mediators Inflamm       Date:  2021-09-23       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.